SCHEMBL6547698

SCHEMBL6547698

Clc1ccccc1N=C(c1ccccc1)c1ccccc1

nearest known ligand 0.75

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ESR1 P03372 4/20 0.75
ESR2 Q92731 4/20 0.75
HTR3E A5X5Y0 2/20 0.57
HTR3B O95264 2/20 0.57
HTR3A P46098 2/20 0.57
HTR3D Q70Z44 2/20 0.57
HTR3C Q8WXA8 2/20 0.57
TAAR1 Q96RJ0 1/20 0.50
ALDH1A1 P00352 5/20 0.47
GAA P10253 2/20 0.46
NOS3 P29474 2/20 0.44
NOS1 P29475 2/20 0.44
NOS2 P35228 2/20 0.44
LMNA P02545 2/20 0.44
MAPT P10636 2/20 0.44
L3MBTL1 Q9Y468 2/20 0.44
TDP1 Q9NUW8 1/20 0.44
NPFFR1 Q9GZQ6 1/20 0.40
NPFFR2 Q9Y5X5 1/20 0.40
NPC1 O15118 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21078200 0.84 ESR1 (0.56) ESR1ESR2HTR3EHTR3BHTR3A
SCHEMBL11388494 0.81 HTR3E (0.55) ESR1ESR2HTR3EHTR3BHTR3A
SCHEMBL13726464 0.81 HTR3E (0.55) ESR1ESR2HTR3EHTR3BHTR3A
SCHEMBL11388504 0.81 HTR3E (0.55) ESR1ESR2HTR3EHTR3BHTR3A
SCHEMBL16229879 0.77 ESR1 (0.49) ESR1ESR2HTR3EHTR3BHTR3A
SCHEMBL9373546 0.76 HTR3E (0.50) ESR1ESR2HTR3EHTR3BHTR3A
SCHEMBL9373550 0.76 HTR3E (0.50) ESR1ESR2HTR3EHTR3BHTR3A
SCHEMBL11402272 0.76 HTR3E (0.50) ESR1ESR2HTR3EHTR3BHTR3A
SCHEMBL6500347 0.76 MAPT (0.52) ESR1ESR2ALDH1A1GAALMNA
SCHEMBL16229878 0.75 ESR1 (0.46) ESR1ESR2HTR3EHTR3BHTR3A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1100774-B1 IMPROVED ARYLAMINE SYNTHESIS MASSACHUSETTS INST TECHNOLOGY (US) 2004-01-21 EP disclosed
US-6323366-B1 ACTIVATED ARYL GROUP AND AN IMINE GROUP ARE COMBINED, IN THE PRESENCE OF A TRANSITION METAL CATALYST FOR FORMATION OF A CARBON-NITROGEN BOND BETWEEN THE ACTIVATED CARBON OF THE ARENE AND IMINE NITROGEN; CONVERTING TO ARYLAMINE MASSACHUSETTS INSTITUTE OF TECHNOLOGY 2001-11-27 US disclosed